Reaction Biology Corporation adquiere ProQinase GmbH

Corporate Breaking News

Home : Reaction Biology Corporation adquiere ProQinase GmbH

Feb 05 2019	Reaction Biology Corporation adquiere ProQinase GmbH
ChinaEquity Group se convertirá en accionista mayoritario de RBC MALVERN, Pennsylvania y BEIJING, 5 de febrero de 2019 /PRNewswire/ -- Reaction Biology Corporation (www.reactionbiology.com) ("RBC") y ChinaEquity Group (www.chinaequity.net) ("CEG") anunciaron hoy la conclusión de una...


Source:https://www.prnewswire.com:443/news-releases/reaction-biology-corporation-adquiere-proqinase-gmbh-871777477.html

Related News
» Johnson Fistel, LLP Announces Investigations of AbbVie Inc., Macquarie Infrastructure Corporation, OPKO Health, Inc. and Uxin Limited; Investors Encouraged to Contact Firm » Reaction Biology Corporation erwirbt ProQinase GmbH